11Managing lupus patients during pregnancy
Introduction
Systemic lupus erythematosus (SLE) is an auto-immune disease with significant female predominance. The onset during reproductive years, coupled with improved survival, has led to increased numbers of pregnancies in women with SLE. The pregnancy outcomes have also significantly improved. The rate of pregnancy loss has decreased from 43% to 17% in recent years [1]. However, SLE patients have fewer children than their normal counterparts, and SLE pregnancy still carries a high risk of complications [2], [3], [4]. A multidisciplinary approach, with close medical, obstetric and neonatal monitoring, is essential for optimal outcomes. This chapter highlights major issues in SLE pregnancy and discusses the management strategies to minimise maternal and foetal risks.
Section snippets
Pregnancy planning in SLE
Active SLE at the time of conception is known to be the strongest predictor of adverse pregnancy outcomes [5]. Hence, ideally, all pregnancies in women with SLE should be planned during periods of disease control. Unplanned pregnancies during periods of disease activity highlight the often neglected need of effective contraceptive counselling of all young women with SLE [6]. Natural and barrier methods of contraception have a high failure rate and may not be sufficient for a patient with active
Pre-conception evaluation
Pre-conception assessment is an essential component of pregnancy planning in women with SLE. In a limited number of patients, pregnancy may pose an unacceptably high maternal risk, justifying an advice to defer or avoid pregnancy (Table 1). If there are no contraindications, the patient should undergo pre-conception counselling, maternal and foetal risk assessment and medication review, before conception (Fig. 1). A complete set of autoantibodies should be obtained as certain specific maternal
Pre-pregnancy counselling
SLE pregnancies are considered to be of high risk. All patients should be counselled about the possible issues, including the risk of disease flares, higher rates of pregnancy complications, sub-optimal obstetric outcomes and the risk of neonatal lupus syndromes (NLSs). The need for optimal disease control with safe medications during pregnancy should be explained.
Ante-natal management in SLE patients
Ante-natal management of pregnant patients with SLE requires a close collaboration between rheumatologist and obstetrician. The monitoring should be more frequent and detailed than the usual standard of care. Each visit should include a thorough physical examination, routine laboratory tests and specific investigations, tailored to the risk profile of the particular pregnancy (Table 3). Certain situations, such as disease flare or the presence of specific antibodies, require specific
Summary
Pregnancy in women with SLE is a high-risk condition. Despite considerable improvement in success rates, substantially high maternal and foetal morbidity and mortality still remain a cause for concern. Disease activity may worsen during pregnancy and in turn may increase the risk of other maternal and foetal complications. Recognition and treatment of disease flares and pre-eclampsia, during SLE pregnancy, is fraught with difficulties, including overlapping features, lack of specific diagnostic
References (91)
- et al.
Hormone replacement and contraceptive therapy in autoimmune diseases
Journal of Autoimmunity
(2012) - et al.
Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling
Contraception
(2006) The Hopkins Lupus Pregnancy Center: ten key issues in management
Rheumatic Disease Clinics of North America
(2007)- et al.
Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus
American Journal of Obstetrics and Gynecology
(2005) - et al.
Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy
Best Practice & Research Clinical Obstetrics & Gynaecology
(2011) - et al.
The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants
Journal of the American College of Cardiology
(2010) - et al.
Nonsteroidal antiinflammatory drug use among women and the risk of birth defects
American Journal of Obstetrics and Gynecology
(2012) - et al.
The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines
Canadian Journal of Cardiology
(2011) - et al.
Health characteristics and outcomes of two randomized vitamin D supplementation trials during pregnancy: a combined analysis
The Journal of Steroid Biochemistry and Molecular Biology
(2013 Jul) Is vitamin D supplementation in pregnancy advisable?
Lancet
(2013 Jun)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
Journal of Thrombosis and Haemostasis
Management of antiphospholipid syndrome in pregnancy
Rheumatic Disease Clinics of North America
A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy
Obstetrics & Gynecology
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition)
Chest
First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss
Blood
A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group
American Journal of Obstetrics and Gynecology
Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome
International Journal of Gynaecology & Obstetrics
Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study
American Journal of Cardiology
Uterine artery Doppler flow studies in obstetric practice
American Journal of Obstetrics and Gynecology
Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period
Journal of Rheumatology
A national study of the complications of lupus in pregnancy
American Journal of Obstetrics and Gynecology
The effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus
Arthritis Care & Research (Hoboken)
Pregnancy outcomes in women with systemic lupus erythematosus
Journal of Maternal-Fetal Medicine
Management of pregnancy in systemic lupus erythematosus
Nature Reviews Rheumatology
Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality?
Arthritis Care & Research (Hoboken)
Combined oral contraceptives in women with systemic lupus erythematosus
The New England Journal of Medicine
A trial of contraceptive methods in women with systemic lupus erythematosus
The New England Journal of Medicine
Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery
Lupus
Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution
Clinical Reviews in Allergy & Immunology
Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies
Rheumatology (Oxford)
The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications
Journal of Rheumatology
Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome
Nephrology Dialysis Transplantation
Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience
Arthritis & Rheumatism
Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies
British Journal of Rheumatology
Hydroxychloroquine in lupus pregnancy
Arthritis & Rheumatism
The impact of increased lupus activity on obstetric outcomes
Arthritis & Rheumatism
Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy
Clinical Rheumatology
Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis
Journal of Rheumatology
Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus
Lupus
Decrease in complement (C3) levels during systemic lupus erythematosus pregnancy is associated with higher rates of pre-eclampsia
Arthritis & Rheumatism
Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort
PLoS Medicine
Early risk factors for pregnancy loss in lupus
Obstetrics & Gynecology
Maternal and foetal outcomes in pregnant patients with active lupus nephritis
Lupus
Lupus anticoagulant, but not anticardiolipin antibody, predicts adverse pregnancy outcome in patients with antiphospholipid antibodies
Arthritis & Rheumatism
Spectrum of cardiac involvement in neonatal lupus
Scandinavian Journal of Immunology
Cited by (134)
Pregnancy in systemic lupus erythematosus
2023, Best Practice and Research: Clinical RheumatologyThe Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy
2022, Rheumatic Disease Clinics of North AmericaManaging Specific Cardiac Conditions During Pregnancy, Labor, and Delivery
2022, Maternal Cardiac Care: A Guide to Managing Pregnant Women with Heart DiseasePregnancy and Pulmonary Arterial Hypertension: A Case Report
2021, Open Respiratory ArchivesLeveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies
2021, Trends in Molecular MedicineThe impact of antiphospholipid antibodies/antiphospholipid syndrome on systemic lupus erythematosus
2024, Rheumatology (United Kingdom)